But those genes may not be present in many of the other types of infections. To combat that, scientists are trying to develop drugs to remove potentially harmful parts. One such drugs is choriacin, a form of “coughing cough.” Studies have already shown choriacin to inhibit the growth of fungi that are common in childhood, including some of the most common pathogens. Choriacin also suppresses a host of other immune factors. Researchers using the treatment had no difficulty removing some infectious agents from blood, food or the body. So much for effective treatment.
To test the merits of choriacin in a child, the researchers looked into a series of 10,000 children between the ages of 5 and 12 who had been vaccinated. The researchers began by creating an individual blood sample that included a few samples per child. Two of the children who received some choriacin were also allowed to start drinking water and eating as often as possible in the pediatric areas. To take care of all the children, the treatment group gave each one a daily dose of the chemical choriacin (40 mg/kg body weight). While the children were not given any drugs, the researchers injected each child with 10 ml of choriacin every day for four days, while they also injected their parents with choriacin every day for two days. During this time, each of the children received an oral choriacin injection every day. Of course, this is just a sample of choriacin injections. They were then divided up according to the child’s body weight and level of susceptibility to illnesses. This allowed Dr. Eric Boudreau, professor of medical microbiology at Michigan State University and lead investigator for Choriacin, to predict that a large number of children with common types of common infections were at high risk to suffer from those same infections on a daily basis. The number of children living in neighborhoods with no direct health care coverage did not drop because of the choriacin injection strategy and did not reach those who were not vaccinated. Dr. Boudreau confirmed the effectiveness of the treatment with the new data that is being collected by the Centers for Disease Control and Prevention (CDC.) Dr. Boudreau said the results show that these drugs can be effective.
Choriacin is used to treat many common gastrointestinal, skin, and respiratory strains of common bacteria. In this method, two forms of the drug are prepared by inserting a substance called a tetracycline in the skin. Dr. Boudreau also reported a successful treatment of the other immune systems in this patient . His group now wants to demonstrate the efficacy of choriacin to treat “lighter-skinned children.” The results of the previous study are expected to be available in future publication of this journal.
The investigators also reviewed data from a second study that was conducted with children from the same age group. The results showed more severe infections and a slightly greater incidence of bacterial infections among children with severe illnesses. The most common cause of serious infections in children with severe illnesses as measured by the percentage of those with chronic conditions increased by 1.3 percent.